Treatment of Affective Disorders
AssigneeVanda Pharmaceuticals Inc.
InventorsMihael Polymeropoulos, Christos Polymeropoulos, Changfu Xiao
Life of this patent
Estimating the term…
Abstract
Embodiments of the invention relate generally to the treatment of affective disorders and, more particularly, to the treatment of affective disorders in a patient of Majority Black African ancestry.
Claims22
A method of treating a Majority Black African patient suffering from an affective disorder comprising:
- administering to said patient an amount of tasimelteon effective to treat said affective disorder.
A method of entraining to a 24-hour sleep-wake cycle in which the patient goes to sleep at or near a target bedtime and awakens at or near a target wake time following a daily sleep period of approximately 7 to 9 hours:
- a circadian rhythm, a cortisol rhythm, and/or a melatonin rhythm of a Majority Black African patient suffering from an affective disorder, the method comprising:
- orally administering to the patient 20 mg of tasimelteon once daily before a target bedtime.
19-23. (canceled)
25-34. (canceled)
In a method of administering tasimelteon to a patient, the improvement comprising selecting as such patient a Majority Black African patient suffering from an affective disorder.
Dependencies are inferred from the claim text.